Skip to main content

Advertisement

SpringerLink
Log in

Cancer therapy

Immunotherapy at all stages of hepatocellular carcinoma

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A flurry of emerging treatment options is transforming the therapeutic landscape of hepatocellular carcinoma; two new studies highlight the complexities and gaps in knowledge, but also hint at a greater understanding of how to apply immunotherapy in early and advanced disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wang, K. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02786-7 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kim, H.-D. et al. Nat. Med. https://doi.org/10.1038/s41591-024-02824-y (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Qin, S. et al. Lancet 402, 1835–1847 (2023).

    Article  CAS  PubMed  Google Scholar 

  4. de Gramont, A. et al. Lancet Oncol. 13, 1225–1233 (2012).

    Article  PubMed  Google Scholar 

  5. Wakelee, H. A. et al. Lancet Oncol. 18, 1610–1623 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Huang, A. C. et al. Nature 545, 60–65 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhu, A. X. et al. Nat. Med. 28, 1599–1611 (2022).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK

    David J. Pinato, Claudia A. M. Fulgenzi & Antonio D’Alessio

  2. Department of Translational Medicine, Università Del Piemonte Orientale “A. Avogadro”, Novara, Italy

    David J. Pinato & Antonio D’Alessio

Authors
  1. David J. Pinato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia A. M. Fulgenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio D’Alessio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Pinato.

Ethics declarations

Competing interests

D.J.P. received lecture fees from ViiV Healthcare, Bayer Healthcare, BMS, Roche, Eisai and Falk Foundation; travel expenses from BMS and Bayer Healthcare; consulting fees for Mina Therapeutics, EISAI, Roche, DaVolterra, Mursla, Exact Sciences and Astra Zeneca; and research funding (to their institution) from MSD and BMS. A.D. received educational support for congress attendance from Roche.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pinato, D.J., Fulgenzi, C.A.M. & D’Alessio, A. Immunotherapy at all stages of hepatocellular carcinoma. Nat Med 30, 640–641 (2024). https://doi.org/10.1038/s41591-024-02828-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-024-02828-8

  • Springer Nature America, Inc.

Search

Navigation